Human Botulism Immune Globulin for the Treatment of Infant Botulism
Top Cited Papers
- 2 February 2006
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (5) , 462-471
- https://doi.org/10.1056/nejmoa051926
Abstract
We created the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV), which neutralizes botulinum toxin, and evaluated its safety and efficacy in treating infant botulism, the intestinal-toxemia form of human botulism.Keywords
This publication has 20 references indexed in Scilit:
- First Case of Infant Botulism Caused by Clostridium baratii Type F in CaliforniaJournal of Clinical Microbiology, 2005
- Infant Botulism Acquired from Household Dust Presenting as Sudden Infant Death SyndromeJournal of Clinical Microbiology, 2005
- Dual Toxin-Producing Strain of Clostridium botulinum Type Bf Isolated from a California Patient with Infant BotulismJournal of Clinical Microbiology, 2004
- A Case of Infant Botulism due to Neurotoxigenic Clostridium butyricum Type E Associated with Clostridium difficile ColitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Clostridium difficile Colitis Associated with Infant Botulism: Near‐Fatal Case Analogous to Hirschsprung's EnterocolitisClinical Infectious Diseases, 1999
- Antitoxin Levels in Botulism Patients Treated with Trivalent Equine Botulism Antitoxin to Toxin Types A, B, and EThe Journal of Infectious Diseases, 1984
- Protective role of human milk against sudden death from infant botulismThe Journal of Pediatrics, 1982
- Quantitative Evidence of Intestinal Colonization by Clostridium botulinum in Four Cases of Infant BotulismThe Journal of Infectious Diseases, 1980
- Honey and other environmental risk factors for infant botulismThe Journal of Pediatrics, 1979
- Infant botulism. Epidemiological, clinical, and laboratory aspectsJAMA, 1977